Inventor · disambiguated record
Aimee Richardson Usera
Also filed as: USERA AIMEE · USERA AIMEE R · USERA AIMEE RICHARDSON
8 granted patents·11 pending applications·29 citations·filing 2006–2023
84Inventor score
Top patents by PatentIndex Score
19 records- 0193US10786576B2Fatty acids and their use in conjugation to biomoleculesNOVARTIS AG·Filed 2018·Granted Sep 29, 2020·5 cites·33 claims
- 0284US9266925B2Cyclic polypeptides for the treatment of heart failureZECRI FREDERIC·Filed 2014·Granted Feb 23, 2016·8 cites·23 claims
- 0380US9683019B2Cyclic polypeptides for the treatment of heart failureZECRI FREDERIC·Filed 2015·Granted Jun 20, 2017·3 cites·19 claims
- 0480US9359400B2Site-specific chemoenzymatic protein modificationsUSERA AIMEE·Filed 2014·Granted Jun 7, 2016·8 cites·9 claims
- 0579US2024066132A1Novel fatty acids and their use in conjugation to biomoleculesNOVARTIS AG·Filed 2023·Application pending·0 cites
- 0678US9931372B2Synthetic apelin fatty acid conjugates with improved half-lifeNOVARTIS AG·Filed 2016·Granted Apr 3, 2018·3 cites·16 claims
- 0777US10975120B2Site-specific chemoenzymatic protein modificationsNOVARTIS AG·Filed 2018·Granted Apr 13, 2021·1 cites·22 claims
- 0875US10588980B2Fatty acids and their use in conjugation to biomoleculesNOVARTIS AG·Filed 2015·Granted Mar 17, 2020·1 cites·24 claims
- 0972US11752211B2Fatty acids and their use in conjugation to biomoleculesNOVARTIS AG·Filed 2020·Granted Sep 12, 2023·0 cites·2 claims
- 1068US2022089639A1Site-specific chemoenzymatic protein modificationsNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1165US2022249614A1Methods of treating or ameliorating metabolic disorders using growth differentiation factor 15 (gdf-15)NOVARTIS AG·Filed 2022·Application pending·0 cites
- 1257US2024216513A1Fatty acid-bifunctional degrader conjugates and their methods of useNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1356US2024247042A1Glucagon like peptide compoundsNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1452US2019000923A1Methods of treating or ameliorating metabolic disorders using growth differentiation factor 15 (gdf-15)NOVARTIS AG·Filed 2016·Application pending·0 cites
- 1551US2017233443A1Cyclic polypeptides for the treatment of heart failureNOVARTIS AG·Filed 2017·Application pending·0 cites
- 1650US2016237116A1Site-specific chemoenzymatic protein modificationsNOVARTIS AG·Filed 2016·Application pending·0 cites
- 1740US2016166634A1Bioconjugates of synthetic apelin polypeptidesCAPLAN SHARI LYNN·Filed 2016·Application pending·0 cites
- 1836US2009291923A1Trioxane dimers having high anticancer and long-lasting antimalarial activitiesJOHNS HOPKINS UNIVERSOTY·Filed 2006·Application pending·0 cites
- 1936US2017107248A1Site specific protein modificationsNOVARTIS AG·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Aimee Richardson Usera files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →